Please assess the completion status of the following clinical trial:

Trial Title: Changes in fMRI and Neurocognitive Function in Women With Pre-eclampsia

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:Severe Pre-Eclampsia defined by~* Symptoms of central nervous system dysfunction (New onset cerebral or visual disturbance, such as: Photopsia, scotomata, cortical blindness, retinal vasospasm)~* Severe headache (ie, incapacitating, the worst headache I've ever had) or headache that persists and progresses despite analgesic therapy~* Altered mental status~* Hepatic abnormality (Severe persistent right upper quadrant or epigastric pain unresponsive to medication and not accounted for by an alternative diagnosis or serum transaminase concentration ≥ twice normal, or both)~* Severe blood pressure elevation (Systolic blood pressure ≥160 mmHg or diastolic blood pressure ≥110 mmHg on two occasions at least four hours apart while the patient is on bedrest (unless the patient is on antihypertensive therapy))~* Thrombocytopenia (\<100,000 platelets/microL)~* Renal abnormality (Progressive renal insufficiency (serum creatinine \>1.1 mg/dL or doubling of serum creatinine concentration in the absence of other renal disease))~* Pulmonary edema~  15 English-speaking pregnant controls with uncomplicated pregnancy matched by age and gestational age will be enrolled from the antenatal clinic or the labor ward.~Exclusion Criteria:~* History of symptomatic cerebrovascular disease with substantial residual deficit~* History of alcoholism~* History of psychiatric illness~* History of claustrophobia~* Renal failure (creatinine \> 2.0 mg/dl)~* Patients with less than a 7th grade education or unable to read and thus unable complete the neuropsychological testing~* Patients with bodily implants unsafe for MRI use

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Pre-Eclampsia (Type: None): 15 English-speaking women with severe pre-eclampsia
- Control (Type: None): 15 English-speaking pregnant controls with uncomplicated pregnancy matched by age and gestational age

Based on this trial design, predict the completion outcome and termination type (if applicable).